Skip to main content
Caplight Logo









Mitem Pharma

Mitem Pharma

Private
MassyHealthcare & Life Scienceshttps://mitempharma.com

Last Round

Corporate Funding

Sep 25, 2024

Total Funding Raised

$10.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Mitem Pharma is a pharmaceutical company that specializes in the revitalization, development, and commercialization of drugs of major therapeutic interest (MITMs).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

Medicines of Major Therapeutic InterestMITMsspecialty pharmadrug life cycle managementdrug acquisitionfabless pharmaessential medicinesorphan drugsrare disease drugsmature drugsdrug commercializationpharma supply chainmarket accessregulatory affairshematologyendocrinology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mitem Pharma Comparables

Compare Mitem Pharma with similar companies based on industry and business-model similarity.

Mitem Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Laboratoires Delbert
86%
Essential Pharma
80%
Pharmanovia
78%

Mitem Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingSep 25, 2024
Growth EquityApr 25, 2022

Mitem Pharma Investors

Notable investors and investment history

Mitem Pharma investors
InvestorRounds
Access Capital PartnersCorporate Funding
TechLife CapitalCorporate Funding, Growth Equity
SWEN Capital PartnersCorporate Funding
MACSFCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 89% MoM, from 782 to 1.5K.

  • Jan 7, 2026

    Monthly visitors grew 464% MoM, from 83 to 468.

Mitem Pharma Filings

Explore SEC and related filing metadata, where available.

Mitem Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mitem Pharma's valuation, stock price, and market status.

Is Mitem Pharma a public or private company?

Mitem Pharma is a private company.

What is the current stock price of Mitem Pharma?

Mitem Pharma is a private company, so its shares have no public market price. Caplight tracks Mitem Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Mitem Pharma worth (valuation)?

Valuation information for Mitem Pharma is not publicly available.

Can I buy Mitem Pharma stock?

Mitem Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Mitem Pharma's last funding round?

Mitem Pharma's most recent funding round was Corporate Funding on September 25, 2024.

Who are the main investors in Mitem Pharma?

Key investors in Mitem Pharma include TechLife Capital.

Will Mitem Pharma IPO soon?

No public IPO plans have been announced for Mitem Pharma.

How can I track Mitem Pharma secondary market activity?

Caplight tracks bids, offers, and trades in Mitem Pharma's shares on secondary markets.

Firmographic Details

HeadquartersMassy
Employee Range16
Year Founded2016
Last FundingSep 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?